• Issue

    European Journal of Haematology: Volume 112, Issue 2

    141-316
    February 2024
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 141-143
  • First Published: 16 January 2024

REVIEWS

Open Access

Current perspectives on resistance to chimeric antigen receptor T-cell therapy and strategies to improve efficacy in B-cell lymphoma

Shin Yeu Ong,  Yunxin Chen,  Melinda Si Yun Tan,  Aloysius Yew Leng Ho,  William Ying Khee Hwang,  Francesca Lorraine Wei Inng Lim, 
  • Pages: 144-152
  • First Published: 29 March 2023
Free Access

Mesenchymal stromal cells and CAR-T cells in regenerative medicine: The homing procedure and their effective parameters

Hanieh Kolahi Azar,  Aylar Imanpour,  Hanieh Rezaee,  Fatemeh Ezzatifar,  Zeinab Zarei-Behjani,  Mohammadreza Rostami,  Mahmoud Azami,  Nima Behestizadeh,  Nima Rezaei, 
  • Pages: 153-173
  • First Published: 31 May 2023
Free Access

Are we ready for personalized CAR-T therapy?

Anna Strzelec,  Grzegorz Helbig, 
  • Pages: 174-183
  • First Published: 11 July 2023
Open Access

Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T-cells (CAR-T): A comprehensive review on incidence, risk factors and current management

Eugenio Galli,  Alberto Fresa,  Silvia Bellesi,  Elisabetta Metafuni,  Elena Maiolo,  Ilaria Pansini,  Filippo Frioni,  Francesco Autore,  Maria Assunta Limongiello,  Idanna Innocenti,  Sabrina Giammarco,  Patrizia Chiusolo,  Gina Zini,  Federica Sorà, 
  • Pages: 184-196
  • First Published: 25 July 2023
Free Access

Chimeric antigen receptor T-cell therapy in hematologic malignancies: Successes, challenges, and opportunities

Matthew Ho,  Saurabh Zanwar,  Jonas Paludo, 
  • Pages: 197-210
  • First Published: 06 August 2023
Free Access

Antigen loss following CAR-T cell therapy: Mechanisms, implications, and potential solutions

Archana Mishra,  Rituparna Maiti,  Prafull Mohan,  Pooja Gupta, 
  • Pages: 211-222
  • First Published: 13 September 2023
Open Access

Tumor microenvironment and CAR-T cell immunotherapy in B-cell lymphoma

Fengqing Cai,  Junfeng Zhang,  Hui Gao,  Hongqiang Shen, 
  • Pages: 223-235
  • First Published: 14 September 2023
Open Access

Optimizing CAR-T cell therapy in adults with B-cell acute lymphoblastic leukemia

Vaibhav Agrawal,  Lindsey Murphy,  Hoda Pourhassan,  Vinod Pullarkat,  Ibrahim Aldoss, 
  • Pages: 236-247
  • First Published: 29 September 2023

ORIGINAL ARTICLES

Open Access

Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors

Somsak Prasongtanakij,  Sarinthip Preedagasamzin,  Bunyada Jittorntrum,  Usanarat Anurathapan,  Teeraya Puavilai,  Pimjai Niparuck,  Pichika Chantrathammachart,  Thanakrit Piyajaroenkij,  Kitipong Uaesoontrachoon,  Ryosuke Uchibori,  Keiya Ozawa,  Ken Ohmine,  Suradej Hongeng, 
  • Pages: 248-256
  • First Published: 24 May 2023

Application of thromboelastography to predict the severity of bleeding after chimeric antigen receptor (CAR)-T cell therapy in patients with hematological malignancy

Liu Chen,  Shuyi Ding,  Yin Cheng,  Linghui Zhou,  Jiali Yan,  Qiong Cheng,  Aiyun Jin,  Xiaoyu Zhou,  He Huang,  Yongxian Hu, 
  • Pages: 257-265
  • First Published: 12 September 2023

Adaptive functioning and academic achievement in pediatric survivors of acute lymphoblastic leukemia: Associations with executive functioning, socioeconomic status, and academic support

Victoria C. Seghatol-Eslami,  Edwin W. Cook III,  Noha Sharafeldin,  Julie Wolfson,  Donna L. Murdaugh, 
  • Pages: 266-275
  • First Published: 05 October 2023
Open Access

Allogeneic hematopoetic stem cell transplant for patients with refractory T-Cell lymphomas

Radwan Massoud,  Hassan Naim,  Evgeny Klyuchnikov,  Dietlinde Janson,  Christine Wolschke,  Francis Ayuk,  Nicolaus Kröger, 
  • Pages: 276-285
  • First Published: 16 October 2023
Open Access

Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A

Mark T. Reding,  María Teresa Álvarez-Román,  Giancarlo Castaman,  Maissaa Janbain,  Tadashi Matsushita,  Karina Meijer,  Kathrin Schmidt,  Johannes Oldenburg, 
  • Pages: 286-295
  • First Published: 24 October 2023

MDS/CMML from resource-limited region: Characteristics and comparison to tertiary reference European center

Anna Sevoyan,  Arsène Mekinian,  Fatiha Chermat,  Lionel Adès,  A. Ivanyan,  Pierre Fenaux,  Yervand Hakobyan, 
  • Pages: 296-300
  • First Published: 11 October 2023

Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data

Ian Pang,  Peggy Chen,  Gertrude V. Trinh,  Mats Remberger,  Igor Novitzky-Basso,  Armin Gerbitz,  Dennis D. Kim,  Rajat Kumar,  Wilson Lam,  Arjun D. Law,  Jeffrey H. Lipton,  Auro Viswabandya,  Ivan Pasic,  Jonas Mattsson,  Fotios V. Michelis, 
  • Pages: 301-309
  • First Published: 13 October 2023

CASE REPORT

Open Access

Three cases of late-onset post CAR-T therapy isolated CNS relapse in R/R large B-cell lymphoma

Huiying Zhu,  Zhe Zhuang,  Wei Wang,  Danqing Zhao,  Wei Zhang,  Daobin Zhou,  Yan Zhang, 
  • Pages: 310-313
  • First Published: 18 September 2023

LETTER TO THE EDITOR

Validation of the GATMO score in predicting non-relapse mortality following hematopoietic cell transplant in multiple myeloma patients

Hussein Awada,  Adel Hajj Ali,  Mohammad Zeineddine,  Mohammad Rashid,  Faiz Anwer,  Betty Hamilton,  Craig Sauter,  Louis Williams,  Jack Khouri, 
  • Pages: 314-316
  • First Published: 07 October 2023